Changes in Iron Metabolism Induced by Anti-Interleukin-6 Receptor Monoclonal Antibody are Associated with an Increased Risk of Infection

(1) Background: Treatment of patients with rheumatoid arthritis (RA) with an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody (tocilizumab) has been found to influence iron metabolism. The objective of the present study was to ascertain whether changes in iron metabolism induced by anti-IL-6R bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, Renata, Batista, Frederico, Seguro Paula, Filipe, Delgado Alves, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789697/
https://www.ncbi.nlm.nih.gov/pubmed/31261772
http://dx.doi.org/10.3390/ph12030100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789697/
https://www.ncbi.nlm.nih.gov/pubmed/31261772
http://dx.doi.org/10.3390/ph12030100

Ejemplares similares